WHO ICTRP trial
Propranolol and hemodynamics and sedation
IRCT20210614051574N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20210614051574N1 |
|---|---|
| Public title | Propranolol and hemodynamics and sedation |
| Scientific title | Evaluation of the effect of oral propranolol on hemodynamics and sedation of patients in stereotaxic surgery |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Brain Tumor. Malignant neoplasm of brain stem;C71.7 |
| Interventions | Intervention 1: Intervention group: Patients in this group receive propranolol in a dose of 20 mg, 2 hours before the operation. They will also be anesthetized with fentanyl and midazolam. Intervention 2: Control group: Patients in this… |
| Registration date | Jul 7, 2021 |
| Target size | 72 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: